Journal article
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study
- Abstract:
- Objective: To evaluate caffeine prescribing practices in a tertiary neonatal unit, focusing on initiation, dose adjustment, discontinuation and recommencement, and to assess associations with gestational age and respiratory support. Design: Retrospective observational study. Setting: Neonatal unit, John Radcliffe Hospital, Oxford, United Kingdom. Patients: Preterm infants born ≤32 weeks gestation and admitted between 1 February 2022 and 31 October 2023. Data extracted from paper patient records included daily caffeine dosing, initiation, discontinuation, recommencement, coadministration with doxapram, demographics and duration of respiratory support. Associations between caffeine administration and clinical factors such as gestational age were assessed using regression. Results: 168 admissions were analysed from 163 infants. Caffeine was typically initiated with a loading dose of 20 mg/kg, and maintenance doses ranged from 5 mg/kg/day to 25 mg/kg/day. There were 1–8 dose adjustments per admission. Doxapram was administered to 19 infants. Caffeine was discontinued at a median (IQR) postmenstrual age of 34.0 (33.9–34.7) weeks and was recommenced in four infants. Gestational age at birth was negatively correlated with postmenstrual age at discontinuation (r(CI) –0.33 (–0.51 to –0.12), p=0.0029; R²=0.11) and infants born at lower gestational ages received higher doses. Conclusion: Caffeine therapy in this unit showed marked variability in dosing, discontinuation and recommencement, highlighting the individualised nature of bedside decision-making, which may reflect clinical response to therapy.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 888.0KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmjpo-2025-004301
Authors
+ John Fell Oxford University Press Research Fund
More from this funder
- Funder identifier:
- 10.13039/501100004789
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ Paediatrics Open More from this journal
- Volume:
- 10
- Issue:
- 1
- Pages:
- e004301
- Article number:
- bmjpo-2025-004301
- Publication date:
- 2026-03-03
- Acceptance date:
- 2026-02-08
- DOI:
- EISSN:
-
2399-9772
- ISSN:
-
2399-9772
- Language:
-
English
- Keywords:
- Pubs id:
-
2385297
- Local pid:
-
pubs:2385297
- Source identifiers:
-
3820740
- Deposit date:
-
2026-03-04
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record